Gene · 3399
Papers2,841
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,841
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| BRAF(V600E) mutation together with loss of Trp53 or pTEN drives the origination of hairy cell leukemia from B-lymphocytes. | Mol Cancer | 2023 | 37543582 | PubTator, text mining | PubMed |
| Topography of mutational signatures in human cancer. | Cell Rep | 2023 | 37540596 | PubTator, text mining | PubMed |
| Two rare cancers of the exocrine pancreas: to treat or not to treat like ductal adenocarcinoma? | J Cancer Metastasis Treat | 2023 | 37538977 | PubTator, text mining | PubMed |
| Robust induction of functional astrocytes using NGN2 expression in human pluripotent stem cells. | iScience | 2023 | 37534135 | PubTator, text mining | PubMed |
| Therapeutic potential of pomegranate juice-derived nanovesicles in nude mouse benign prostatic hyperplasia (BPH) xenograft model. | Sci Rep | 2023 | 37528206 | PubTator, text mining | PubMed |
| The pseudokinase Trib1 regulates the transition of exhausted T cells to a KLR+ CD8+ effector state, and its deletion improves checkpoint blockade. | Cell Rep | 2023 | 37527035 | PubTator, text mining | PubMed |
| Decoding key cell sub-populations and molecular alterations in glioblastoma at recurrence by single-cell analysis. | Acta Neuropathol Commun | 2023 | 37525259 | PubTator, text mining | PubMed |
| Reversing pancreatic β-cell dedifferentiation in the treatment of type 2 diabetes. | Exp Mol Med | 2023 | 37524865 | PubTator, text mining | PubMed |
| T memory stem cell characteristics in autoimmune diseases and their promising therapeutic values. | Front Immunol | 2023 | 37497231 | PubTator, text mining | PubMed |
| Terminal differentiation of villus tip enterocytes is governed by distinct Tgfβ superfamily members. | EMBO Rep | 2023 | 37493498 | PubTator, text mining | PubMed |
| Radiomics combined with transcriptomics to predict response to immunotherapy from patients treated with PD-1/PD-L1 inhibitors for advanced NSCLC. | Front Radiol | 2023 | 37492391 | PubTator, text mining | PubMed |
| Cleavage of semaphorin 4 C interferes with the neuroprotective effect of the semaphorin 4 C/Plexin B2 pathway on experimental intracerebral hemorrhage in rats. | J Chem Neuroanat | 2023 | 37482144 | PubTator, text mining | PubMed |
| USP1 Expression Driven by EWS::FLI1 Transcription Factor Stabilizes Survivin and Mitigates Replication Stress in Ewing Sarcoma. | Mol Cancer Res | 2023 | 37478161 | PubTator, text mining | PubMed |
| Identification of transcriptional programs using dense vector representations defined by mutual information with GeneVector. | Nat Commun | 2023 | 37474509 | PubTator, text mining | PubMed |
| Dissecting peri-implantation development using cultured human embryos and embryo-like assembloids. | Cell Res | 2023 | 37460804 | PubTator, text mining | PubMed |
| Induction of bronchus-associated lymphoid tissue is an early life adaptation for promoting human B cell immunity. | Nat Immunol | 2023 | 37460638 | PubTator, text mining | PubMed |
| Targeting MYC-driven lymphoma: lessons learned and future directions. | Cancer Drug Resist | 2023 | 37457123 | PubTator, text mining | PubMed |
| TGF-β based risk model to predict the prognosis and immune features in glioblastoma. | Front Neurol | 2023 | 37456651 | PubTator, text mining | PubMed |
| RGMb impacts partial epithelial-mesenchymal transition and BMP2-Induced ID mRNA expression independent of PD-L2 in nonsmall cell lung cancer cells. | Cell Biol Int | 2023 | 37434531 | PubTator, text mining | PubMed |
| Efficient and scalable generation of primordial germ cells in 2D culture using basement membrane extract overlay. | Cell Rep Methods | 2023 | 37426764 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3399/papers?page=15